Company Profile: HistoRx: tissue-based diagnostic solutions for personalized medicine

Author： Dolled-Filhart Marisa   Romeo Elisa   Adams Kathleen   Davis Wendy   Gustavson Mark  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.9, Iss.2, 2012-03, pp. : 185-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Company Profile: N-of-One: realizing personalized medicine

By Carter Jennifer Levin   Elkin Sheryl   Barton Joan  

Personalized Medicine, Vol. 8, Iss. 3, 2011-05 ,pp. : 311-315

Future Medicine

Access to resources Recommend Favorite

Innovative Diagnostic Technologies and Their Significance for Personalized Medicine

By Jain Kewal K.  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 3, 2010-06 ,pp. : 141-147

Adis International

Access to resources Recommend Favorite

Personalized medicine: a competitor or an upgrade of evidence-based medicine?

By Bereczki Daniel  

Personalized Medicine, Vol. 9, Iss. 2, 2012-03 ,pp. : 211-221

Future Medicine

Access to resources Recommend Favorite

Company Profile: Strategic Medicine, Inc. and Strategic Medicine, BV

By Liebman Michael N  

Personalized Medicine, Vol. 10, Iss. 7, 2013-09 ,pp. : 633-637

Future Medicine

Access to resources Recommend Favorite

US FDA and personalized medicine: in vitro diagnostic regulatory perspective

By Težak Živana   Kondratovich Marina V   Mansfield Elizabeth  

Personalized Medicine, Vol. 7, Iss. 5, 2010-09 ,pp. : 517-530

Future Medicine

Access to resources Recommend Favorite